S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial
Schmoll, H, Wittig, BW, Arnold, DA, Riera-Knorrenschild, JRK, Nietsche, DN, Kroening, HK, Mayer, FM, Andel, JA, Ziebermayr, RZ, Scheithauer, WS
Published in Journal for immunotherapy of cancer (12.03.2014)
Published in Journal for immunotherapy of cancer (12.03.2014)
Get full text
Journal Article